Antitumor mechanism of traditional Chinese medicine: a review of gut microbiota-mediated immunotherapy
Journal of Pharmacy and Pharmacology · 16.01.2026 · 78 (1)
DOI: 10.1093/jpp/rgaf128 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 17.01.2026. Verfasst von Wen-Jie Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, 24 Heping Road, Harb…. Hauptthemen laut MEDLINE: Medicine, Chinese Traditional, Gastrointestinal Microbiome, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 217 Literaturangaben. Gefördert von: Wellcome Trust, Natural Science Foundation Key Project of Heilongjiang Province, Young Qihuang Scholar Project of Heilongjiang Province.
Abstract (Originalsprache)
Objectives
Traditional Chinese Medicine (TCM) has garnered significant interest for its role in modulating gut microbiota to inhibit tumor progression. This review aims to systematically elucidate the mechanistic basis for TCM-mediated antitumor activity via gut microbiota modulation. Based on the microbiota-immune axis theory, it also intends to investigate the optimizing effects of TCM on traditional tumor treatment modalities. By establishing a theoretical foundation for the role of TCM in microbiota-mediated immunotherapy, this review also provides evidence supporting its multi-target and cross-organ antitumor properties.
Methods
All the information was collected through library searches and scientific databases. Key findings Gut microbiota dysbiosis promotes tumors not only in the digestive system but also beyond it, via gut-organ-axis signaling and metabolic mechanisms. TCM modulates host immunity both through gut microbiota remodeling and microbial metabolite-mediated activation of immune cells. Similarly, via the gut microbiota, TCM can reduce toxicity and enhance the efficacy of conventional cancer therapies. During TCM treatment, as the gut microbiota undergoes dynamic succession, its regulatory effect on the host immune system exhibits corresponding time-dependent changes.
Conclusions
Research on gut microbiota-mediated TCM immunotherapy demonstrates the theoretical basis for TCM's trans-organ antitumor effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, 24 Heping Road, Harbin, Heilongjiang Province, 150040, China.
ORCID-Profile: Jun Liang
Förderung
- Wellcome Trust
- Natural Science Foundation Key Project of Heilongjiang Province
- Young Qihuang Scholar Project of Heilongjiang Province
Zitieren
APA
Wang, W. J., Liu, T. B., Li, Y. G., Jia, J. F., Zhao, M. Q., Huang, Y. X., Dong, J. G., Xia, Y. G., & Liang, J. (2026). Antitumor mechanism of traditional Chinese medicine: a review of gut microbiota-mediated immunotherapy. Journal of Pharmacy and Pharmacology, 78(1). https://doi.org/10.1093/jpp/rgaf128
Vancouver
Wang WJ, Liu TB, Li YG, Jia JF, Zhao MQ, Huang YX, et al. Antitumor mechanism of traditional Chinese medicine: a review of gut microbiota-mediated immunotherapy. Journal of Pharmacy and Pharmacology. 2026;78(1). doi:10.1093/jpp/rgaf128
BibTeX
@article{Wang2026,
author = {Wang, Wen-Jie and Liu, Tian-Bo and Li, Ya-Ge and Jia, Ju-Fang and Zhao, Meng-Qi and Huang, Yong-Xin and Dong, Jin-Ge and Xia, Yong-Gang and Liang, Jun},
title = {Antitumor mechanism of traditional Chinese medicine: a review of gut microbiota-mediated immunotherapy},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
volume = {78},
number = {1},
doi = {10.1093/jpp/rgaf128}
}
EUVIMED